EVOTEC (1EVT.MI)
| Previous Close | 9.77 |
| Open | 9.92 |
| Bid | 9.91 x N/A |
| Ask | 9.99 x N/A |
| Day's Range | 9.92 - 9.92 |
| 52 Week Range | 7.34 - 21.39 |
| Volume | |
| Avg. Volume | 2,243 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | Aug 14, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ACCESSWIREJust - Evotec Biologics Expands Tech Partnership for Biosimilars with Sandoz
Just - Evotec Biologics expands partnership with Sandoz for development and commercial manufacturing of biosimilars Additional biosimilars potentially to be added to Sandoz development pipeline Further guarantees for Sandoz long-term commercial supply ...
- ACCESSWIRE
Just - Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program
Just - Evotec Biologics will deliver an ultra-rapid, cost-efficient biotherapeutics manufacturing platform solution for the DOD's Manufacturing Optimization Program Manufacturing solution includes seamless integration of accelerated mAb drug development ...
- ACCESSWIRE
Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb
Key scientific achievement advances the joint pipeline in the strategic neuroscience partnership with Bristol Myers Squibb and earns a payment of US$ 20 m to Evotec to progress further research HAMBURG, GERMANY / ACCESSWIRE / June 12, 2024 / Evotec ...
